Similarly, the EZH2-H3K27me3 in synergy with histone deacetylation was reported to repress expression of CDKN1C in SK-BR-3 and BT-474 BC cell lines that overexpresses HER2 (and ER+) [51]. This evidence concerns the gene ERBB2 and breast cancer.